| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 30 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44 |
| Body Types | Overweight |
In 30 type II diabetics, 1g vitamin C daily for 4 months was able to reduce fasting and postprandial markers of oxidation but not influence markers of lipid metabolism or glycemic control.
